ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2075

No Detection of Varicella-Zoster Virus in Temporal Arteries of Patients with Giant Cell Arteritis

Francesco Muratore1, Stefania Croci2, Ione Tamagnini3, Alessandro Zerbini2, Salvatore Bellafiore4, Lucia Belloni5, Luigi Boiardi6, Alessandra Bisagni7, Maria Parmeggiani8, Alberto Cavazza9 and Carlo Salvarani1, 1Rheumatology Unit, Arcispedale S Maria Nuova, IRCCS, Reggio Emilia, Italy, 2Clinical Immunology, Allergy and Advanced Biotechnologies Unit,, Arcispedale S Maria Nuova-IRCCS, Reggio Emilia, Italy, 3Pathology Unit, Department of Oncology, Arsicpedale S Maria Nuova, IRCCS, Reggio Emilia, Italy, 4Pathology Unit, Department of Oncology, Arcispedale S Maria Nuova, Reggio Emilia, Italy, 5Clinical Immunology, Allergy and Advanced Biotechnologies Unit, Arcispedale S Maria Nuova-IRCCS, Reggio Emilia, Italy, 6Rheumatology Unit, Arcispedale S.Maria Nuova, IRCCS, Reggio Emilia, Italy, 7Pathology Unit, Department of Oncology, Arcispedale S Maria Nuova, IRCCS, Reggio Emilia, Italy, 8. Clinical Immunology, Allergy and Advanced Biotechnologies Unit, Arcispedale S Maria Nuova-IRCCS, Reggio Emilia, Italy, 9Pathology Unit, Arcispedale S Maria Nuova-IRCCS, Reggio Emilia, Italy

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: biopsies, Diagnostic Tests, DNA, vasculitis and viruses

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Vasculitis II: Population Studies

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Recent studies found an high prevalence of varicella-zoster virus (VZV) infection in temporal arteries (TAs) from both temporal artery biopsy (TAB)-positive and TAB-negative giant cell arteritis (GCA) patients compared to controls, suggesting that VZV infection may trigger the inflammatory cascade that characterizes GCA (1,2). The aim of our study was to analyze VZV infection in TAs from patients with TAB-positive GCA (biopsy-proven GCA), TAB-negative GCA (patients with negative TAB and a final diagnosis of GCA) and controls (patients with negative TAB and a final diagnosis different from GCA).

Methods: 79 formalin-fixed, paraffin-embedded (FFPE) TABs performed between 2009 and 2012 from 34 TAB-positive GCA patients, 15 TAB-negative GCA patients and 30 controls were retrieved. Six 5-μm sections of all FFPE TABs were cut. The first section was analyzed by immunohistochemistry using a mouse monoclonal antiVZV glycoprotein E (gE) IgG1 antibody (Santa CruzBiotechnology, Dallas, TX) and UltraView DAB Detection Kit (Ventana, Roche, Tucson, Az.). DNA was extracted from the remaining 5 sections with the QIAamp DNA FFPE tissue kit (Qiagen) and analyzed by real-time polymerase chain reaction (PCR) for the presence of VZV with primers for the major DNA binding protein of VZV (ORF 29) using both the VZV ELITe MGB kit (CE-IVD assay) and the primers designed by Gilden et al (1,2). For 10 of the 34 TAB-positive GCA patients, a specimen of temporal artery longer than 2 mm obtained at the time of TAB and immediately stored frozen at -80°C was available. DNA was extracted from these 10 frozen specimens with the RNA/DNA/Protein purification kit (Norgen Biotek) and analyzed by PCR for the presence of VZV DNA. 30 additional 5-μm sections were cut from each of these 10 FFPE TABs for which the frozen specimens were available and analyzed by immunohistochemistry. A FFPE skin lesion from a patient with active infection with VZV was used as positive control.

Results: Immunohistochemical analysis detected VZV antigen in 1/34 (3%) TAB-positive GCA, 0/15 TAB-negative GCA and 0/30 controls, and in none of the 300 sections cut from the 10 FFPE TABs positive for GCA for which the frozen specimens were available. Instead VZV antigen was clearly detected in the skin lesion from a patient with active infection used as positive control. DNA obtained from all TABs was amplifiable. DNA obtained from frozen TABs was more concentrated than that obtained from FFPE TABs which allowed to load a higher quantity of DNA per reaction increasing assay sensitivity. VZV DNA was not detected in any of the FFPE TABs nor in frozen TABs, but was clearly detected in the FFPE skin lesion used as positive control. The histopathologic analysis showed transmural inflammation in all sections and no skip areas were found.

Conclusion: Our data do not support a role for VZV infection in the etiopathogenesis of GCA in Italian patients. References:1. Gilden D, et al. Prevalence and distribution of VZV in temporal arteries of patients with giant cell arteritis. Neurology. 2015 May 12;84(19):1948-55. 2. Nagel MA, et al. Analysis of Varicella-Zoster Virus in Temporal Arteries Biopsy Positive and Negative for Giant Cell Arteritis. JAMA Neurol. 2015 Nov 1;72(11):1281-7.


Disclosure: F. Muratore, None; S. Croci, None; I. Tamagnini, None; A. Zerbini, None; S. Bellafiore, None; L. Belloni, None; L. Boiardi, None; A. Bisagni, None; M. Parmeggiani, None; A. Cavazza, None; C. Salvarani, None.

To cite this abstract in AMA style:

Muratore F, Croci S, Tamagnini I, Zerbini A, Bellafiore S, Belloni L, Boiardi L, Bisagni A, Parmeggiani M, Cavazza A, Salvarani C. No Detection of Varicella-Zoster Virus in Temporal Arteries of Patients with Giant Cell Arteritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/no-detection-of-varicella-zoster-virus-in-temporal-arteries-of-patients-with-giant-cell-arteritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/no-detection-of-varicella-zoster-virus-in-temporal-arteries-of-patients-with-giant-cell-arteritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology